Fosmidomycin-piperaquine combination provides promising malaria treatment
An international research team has conducted successful phase II clinical tests of a new anti-malaria medication...
List view / Grid view
An international research team has conducted successful phase II clinical tests of a new anti-malaria medication...
An ingredient commonly found in toothpaste could be employed as an anti-malarial drug against strains of the malaria parasite that have grown resistant to one of the currently used drugs...
Chloroquine and hydroxychloroquine could make cancer treatments more effective...
Researchers have published two systematic reviews revealing the safety of mefloquine for preventing malaria in travellers...
New research demonstrates that the malaria treatment, artemisinin can now be rapidly produced by genetically engineered moss at an industrial scale...
A patient trial for KAF156, a next-generation antimalarial compound with the potential to treat drug-resistant strains of the malaria parasite has been launched...
17 May 2017 | By Niamh Marriott, Junior Editor
Study shows how a mixture of chitin and silver nanoparticles inhibits growth of mosquito larvae...
20 February 2017 | By Niamh Marriott, Digital Editor
Umeå University researches have established links between patterns of malaria in Kenya and environmental factors measurable by satellite imagery...
15 June 2016 | By Victoria White, Digital Content Producer
Novartis' KAF156 is one of the first antimalarial drug candidates to enter Phase IIb clinical development in more than 20 years...
24 May 2016 | By Victoria White, Digital Content Producer
Lariam, the anti-malarial drug sometimes prescribed to British troops, should be considered only as a drug of last resort, says the Defence Committee...
15 December 2015 | By Victoria White
A new fund – created through a £17m donation from GSK and £5m from Comic Relief – will provide targeted grants over the next five years to organisations on the malaria frontline...
16 October 2015 | By Victoria White
Scientists investigating whether the malaria drug artesunate could have a significant impact on colorectal cancer have launched a crowdfunding project to fund their work...
12 August 2015 | By Katie Sadler, Digital Content Producer, European Pharmaceutical Review
A magnetic blood filtering device is under development by start-up company MediSieve to capture and remove red blood cells infected with drug resistant malaria.
24 July 2015 | By Victoria White
The CHMP has adopted a positive scientific opinion for Mosquirix, making it the first vaccine for the prevention of malaria to reach such a milestone...
16 July 2015 | By Victoria White
Coartem 80/480mg has received WHO prequalification, making it the first high strength ACT antimalarial treatment available for public sector procurement...